SKI Market

Indian Indices

Sensex

83,085.40 -228.53
( -0.27%)

Global Indices

Nasdaq

48,934.28 -588.03
(-1.19%)

Dow Jones

6,820.12 -83.60
(-1.21%)

Hang Seng

54,176.23 358.19
(0.67%)

Nikkei 225

10,300.09 -102.25
(-0.98%)

Forex

USD-INR

90.39 0.07
(0.07%)

EUR-INR

106.79 0.14
(0.13%)

GBP-INR

123.73 0.13
(0.10%)

JPY-INR

0.58 0.00
(-0.49%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Industry :

BSE Code

ISIN Demat

Book Value()

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

EPS(TTM)

Face Value()

Div & Yield %

Back

Marksans Pharma receives USFDA approval for Loperamide Hydrochloride tablets

Nov 19,2025

Marksans Pharma announced USFDA final approval of the Company's wholly owned subsidiary Marksans Pharma Inc.'s Abbreviated New Drug Application (ANDA) for Loperamide Hydrochloride Tablets USP, 2 mg (OTC). This product is bioequivalent to the reference listed drug (RLD), Imodium A-D Tablets, 2mg, of Kenvue Brands LLC (Kenvue) NDA - 019860.

Loperamide Hydrochloride is an anti-diarrheal medication used to control symptoms of acute and chronic diarrhea.

83,085.40 -228.53 ( -0.27%)

48,934.28 -588.03 (-1.19%)

6,820.12 -83.60 (-1.21%)

54,176.23 358.19 (0.67%)

10,300.09 -102.25 (-0.98%)

90.39 0.07 (0.07%)

106.79 0.14 (0.13%)

123.73 0.13 (0.10%)

0.58 0.00 (-0.49%)